New York, NY (PRWEB) August 24, 2014
Men who allegedly suffered heart attacks and other cardiovascular injuries due to prescription testosterone (http://www.drugbot.com/testosterone/) medications are continuing to file cases in federal court, where a multidistrict litigation now includes almost 180 claims, Bernstein Liebhard LLP reports.
According to a Case List updated on August 15th, at least 177 testosterone lawsuits have now been filed in a federal proceeding underway in the U.S. District Court, Northern District of Illinois. Men in these cases allege heart attacks, strokes, blood clots and other life-threatening cardiovascular problems caused by prescription testosterone treatments. Medications involved in this multidistrict litigation, which included just over 150 claims in July, include AndroGel, AndroDerm and Testim, among others. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)
“As we continue to hear from men who suffered serious and life-threatening heart events after taking AndroGel and other medications, we are pleased to see the number of testosterone lawsuits in Illinois federal court increasing at a steady pace,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices.
The number of AndroGel lawsuits, as well as claims involving other prescription testosterone therapies, has been steadily on the rise since January 2014, when the U.S. Food and Drug Administration (FDA) warned about the medications’ possible link to serious cardiovascular injuries. The FDA’s review of these products was announced on January 31, 2014 after two studies associated older men, as well as individuals with pre-existing heart disease, with an elevated risk for strokes, heart attacks and other heart events resulting in death. These individuals were more likely to suffer cardiovascular injuries than men who were not taking testosterone drugs, research found. Testosterone lawsuits now filed in the Northern District of Illinois accuse drug manufacturers of failing to warn the public about these risks.
The FDA entered the next stage of its review last month, when the agency announced its plans to convene a joint meeting of the Reproductive and Urologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee on September 17, 2014. At this time, members will be asked to make recommendations regarding the cardiovascular side effects associated with testosterone drugs, according to a notice posted on the FDA’s website. The Committees also plan to address what factors should be considered when prescribing hormone therapies for men.*
Men who allegedly experienced life-threatening cardiovascular events due to AndroDerm or another low-testosterone therapy may be eligible to receive compensation for injury-related damages. Learn more by visiting Bernstein Liebhard LLP’s website, or call our Firm for a free and confidential case review at the following toll-free number: 800-511-5092.
*fda.gov/AdvisoryCommittees/Calendar/ucm404905.htm, FDA, July 17, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com